The Immune Molecule IL-2 Has a Hidden Opioid Peptide Domain That Relieves Pain
IL-2 contains a structural domain around its 45th residue that resembles opioid peptides and produces pain relief, revealing molecular overlap between immune signaling and the opioid system.
Quick Facts
What This Study Found
IL-2 contains a structural domain resembling opioid peptides around its 45th Tyr residue that mediates analgesic effects, blocked by anti-opioid antibodies, revealing molecular overlap between immune and opioid signaling.
Key Numbers
How They Did This
In-vitro structural analysis of IL-2 identifying opioid-like domains, combined with functional pain assays showing IL-2 analgesia blocked by anti-endorphin, anti-leu-enkephalin, and anti-dynorphin antibodies.
Why This Research Matters
The discovery that an immune molecule contains an opioid-like pain-relieving domain provides molecular evidence for the long-suspected connection between immune activation and pain modulation.
The Bigger Picture
Immune activation during infection often changes pain sensitivity. Finding opioid-like domains within immune molecules provides a molecular basis for understanding why illness changes pain perception.
What This Study Doesn't Tell Us
Structural similarity doesn't guarantee identical function. The physiological relevance of IL-2's analgesic domain at normal immune concentrations is unclear. In-vitro structure-function analysis.
Questions This Raises
- ?Do other cytokines contain opioid-like domains?
- ?Is IL-2's analgesic function clinically relevant during immune activation?
- ?Could IL-2-derived peptides be developed as pain medications?
Trust & Context
- Key Stat:
- Hidden opioid domain The immune molecule IL-2 contains a structural domain resembling endorphin that produces actual pain relief — immune and opioid systems share molecular architecture
- Evidence Grade:
- Preliminary evidence from structural analysis and functional blocking experiments, providing novel insight into immune-opioid molecular overlap.
- Study Age:
- Published in 2000. The concept of molecular overlap between immune and opioid systems has been supported by additional structural and functional discoveries.
- Original Title:
- Interleukin-2: structural and biological relatedness to opioid peptides.
- Published In:
- Neuroimmunomodulation, 8(1), 20-4 (2000)
- Database ID:
- RPEP-00595
Evidence Hierarchy
Frequently Asked Questions
Can an immune molecule relieve pain?
Yes. IL-2, normally known as an immune signaling molecule, has a built-in domain that structurally resembles natural painkillers. This domain can actually relieve pain through opioid receptor mechanisms.
What does this mean for understanding illness and pain?
It explains at the molecular level why immune activation changes pain sensitivity. When your immune system fights infection and releases IL-2, the opioid-like domain may modulate pain — connecting immunity and pain at the molecular level.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00595APA
Jiang, C L; Xu, D; Lu, C L; Wang, Y X; You, Z D; Liu, X Y. (2000). Interleukin-2: structural and biological relatedness to opioid peptides.. Neuroimmunomodulation, 8(1), 20-4.
MLA
Jiang, C L, et al. "Interleukin-2: structural and biological relatedness to opioid peptides.." Neuroimmunomodulation, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Interleukin-2: structural and biological relatedness to opio..." RPEP-00595. Retrieved from https://rethinkpeptides.com/research/jiang-2000-interleukin2-structural-and-biological
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.